logo
Select company
Select metric
10.98%Capital Expenditures Margin
VS
Market
21
Sector
19
Industry
34
History
58
$ 0.86Close
$ 0.79 - $ 3.1 52-Week Range
Ticker Information

Ticker

LEXX

Company Name

LEXARIA BIOSCIENCE CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LEXARIA BIOSCIENCE CORP - Capital Expenditures Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LEXX - CapEx % Historical data
DateCapital ExpenditureCapital Expenditures MarginRevenues
6/30/2025$ 67.66K10.98%$ 615.92K
3/31/2025$ 67.66K12.87%$ 525.92K
12/31/2024$ 67.66K13.62%$ 496.92K
9/30/2024$ 43.01K9.26%$ 464.28K
6/30/2024$ 00%$ 376.85K
3/31/2024$ 00%$ 386K
12/31/2023$ 13.25K4.8%$ 276.01K
9/30/2023$ 33.75K14.92%$ 226.21K
6/30/2023$ -15.44K0%$ 340.79K
3/31/2023$ -8.63K0%$ 347.36K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LEXARIA BIOSCIENCE CORP's latest trailing twelve months (TTM) CapEx % stands at 0%.
  • Over the past 5 years, LEXARIA BIOSCIENCE CORP's average CapEx % has been 41.45%.
  • The median CapEx % for LEXARIA BIOSCIENCE CORP during this period was 12.87%
  • LEXARIA BIOSCIENCE CORP reached its highest CapEx % over the past 5 years at 184.04%.
  • The lowest CapEx % recorded by LEXARIA BIOSCIENCE CORP in the same timeframe 4.8%

LEXARIA BIOSCIENCE CORP's CapEx % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx % Benchmarks
CompanyCapEx %
BRTX : BIORESTORATIVE THERAPIES INC 17.73%IBIO : IBIO INC 4%ERNA : ERNEXA THERAPEUTICS INC 3.89%ICU : SEASTAR MEDICAL HOLDING CORP -RLYB : RALLYBIO CORP -LYRA : LYRA THERAPEUTICS INC -PULM : PULMATRIX INC -VYNE : VYNE THERAPEUTICS INC 24.58%APRE : APREA THERAPEUTICS INC -MGRX : MANGOCEUTICALS INC 12.6%

Definition of Capital Expenditures Margin

[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
CapEx / Revenues
(=) CapEx %
CapEx % for LEXARIA BIOSCIENCE CORP is calculated as follows: CapEx [ $ 0 ] / Revenues [ $ 384.54K ]
(=) CapEx % [ 0% ]

LEXX - Capital Expenditures Margin, Last 5 years

4.8%

Minimum

Dec 31, 2023

184.04%

Maximum

Jun 30, 2022

41.45%

Average

12.87%

Median

CapEx % Benchmark Analysis

The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.47% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
filtered constituents2.85K
min0%
max15.02%
average3.47%
median2.43%
std3.27%